These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 11747054)

  • 1. Changing the first line drug for malaria treatment--cost-effectiveness analysis with highly uncertain inter-temporal trade-offs.
    Goodman CA; Coleman PG; Mills AJ
    Health Econ; 2001 Dec; 10(8):731-49. PubMed ID: 11747054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An economic comparison of chloroquine and sulfadoxine-pyrimethamine as first-line treatment for malaria in South Africa: development of a model for estimating recurrent direct costs.
    Wilkins JJ; Folb PI; Valentine N; Barnes KI
    Trans R Soc Trop Med Hyg; 2002; 96(1):85-90. PubMed ID: 11926003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WHO, the Global Fund, and medical malpractice in malaria treatment.
    Attaran A; Barnes KI; Curtis C; d'Alessandro U; Fanello CI; Galinski MR; Kokwaro G; Looareesuwan S; Makanga M; Mutabingwa TK; Talisuna A; Trape JF; Watkins WM
    Lancet; 2004 Jan; 363(9404):237-40. PubMed ID: 14738799
    [No Abstract]   [Full Text] [Related]  

  • 4. Cost-effectiveness of two versus three or more doses of intermittent preventive treatment for malaria during pregnancy in sub-Saharan Africa: a modelling study of meta-analysis and cost data.
    Fernandes S; Sicuri E; Kayentao K; van Eijk AM; Hill J; Webster J; Were V; Akazili J; Madanitsa M; ter Kuile FO; Hanson K
    Lancet Glob Health; 2015 Mar; 3(3):e143-53. PubMed ID: 25701992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative efficacy and safety of chloroquine and alternative antimalarial drugs: a meta-analysis from six African countries.
    Mengesha T; Makonnen E
    East Afr Med J; 1999 Jun; 76(6):314-9. PubMed ID: 10750517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic efficacy of chloroquine or amodiaquine in combination with sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Papua New Guinea.
    Jayatilaka KD; Taviri J; Kemiki A; Hwaihwanje I; Bulungol P
    P N G Med J; 2003; 46(3-4):125-34. PubMed ID: 16454394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Research influence on antimalarial drug policy change in Tanzania: case study of replacing chloroquine with sulfadoxine-pyrimethamine as the first-line drug.
    Mubyazi GM; Gonzalez-Block MA
    Malar J; 2005 Oct; 4():51. PubMed ID: 16242017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, parallel-group study in Mumbai (Bombay), comparing chloroquine with chloroquine plus sulfadoxine-pyrimethamine in the treatment of adults with acute, uncomplicated, Plasmodium falciparum malaria.
    Gogtay NJ; Desai S; Kadam VS; Kamtekar KD; Dalvi SS; Kshirsagar NA
    Ann Trop Med Parasitol; 2000 Jun; 94(4):309-12. PubMed ID: 10945039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perception of chloroquine efficacy and alternative treatments for uncomplicated malaria in children in a holoendemic area of Tanzania: implications for the change of treatment policy.
    Tarimo DS; Minjas JN; Bygbjerg IC
    Trop Med Int Health; 2001 Dec; 6(12):992-7. PubMed ID: 11737836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness study of three antimalarial drug combinations in Tanzania.
    Wiseman V; Kim M; Mutabingwa TK; Whitty CJ
    PLoS Med; 2006 Oct; 3(10):e373. PubMed ID: 17032059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A trial of Fansidar plus chloroquine or Fansidar alone for the treatment of uncomplicated malaria in Gambian children.
    Bojang KA; Schneider G; Forck S; Obaro SK; Jaffar S; Pinder M; Rowley J; Greenwood BM
    Trans R Soc Trop Med Hyg; 1998; 92(1):73-6. PubMed ID: 9692160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The costs of changing national policy: lessons from malaria treatment policy guidelines in Tanzania.
    Mulligan JA; Mandike R; Palmer N; Williams H; Abdulla S; Bloland P; Mills A
    Trop Med Int Health; 2006 Apr; 11(4):452-61. PubMed ID: 16553928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of malaria control in sub-Saharan Africa.
    Goodman CA; Coleman PG; Mills AJ
    Lancet; 1999 Jul; 354(9176):378-85. PubMed ID: 10437867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How sulfadoxine-pyrimethamine (SP) was perceived in some rural communities after phasing out chloroquine (CQ) as a first-line drug for uncomplicated malaria in Tanzania: lessons to learn towards moving from monotherapy to fixed combination therapy.
    Nsimba SE
    J Ethnobiol Ethnomed; 2006 Jan; 2():5. PubMed ID: 16403225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malaria research and its influence on anti-malarial drug policy in Malawi: a case study.
    Mwendera C; de Jager C; Longwe H; Phiri K; Hongoro C; Mutero CM
    Health Res Policy Syst; 2016 Jun; 14(1):41. PubMed ID: 27246503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of chloroquine-resistant malaria in African children: a cost-effectiveness analysis.
    Sudre P; Breman JG; McFarland D; Koplan JP
    Int J Epidemiol; 1992 Feb; 21(1):146-54. PubMed ID: 1544746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative Study of Effectiveness and Resistance Profile of Chloroquine and Sulfadoxine-Pyrimethamine in Uncomplicated Plasmodium falciparum Malaria in Kolkata.
    Basu A; Saha S; Guha SK
    J Assoc Physicians India; 2015 May; 63(5):32-7. PubMed ID: 26591142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vendor-to-vendor education to improve malaria treatment by private drug outlets in Bungoma District, Kenya.
    Tavrow P; Shabahang J; Makama S
    Malar J; 2003 May; 2():10. PubMed ID: 12812525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Costs and cost-effectiveness of delivering intermittent preventive treatment through schools in western Kenya.
    Temperley M; Mueller DH; Njagi JK; Akhwale W; Clarke SE; Jukes MC; Estambale BB; Brooker S
    Malar J; 2008 Sep; 7():196. PubMed ID: 18826594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring antimalarial drug resistance within National Malaria Control Programmes: the EANMAT experience.
    East African Network for Monitoring Antimalarial Treatment (EANMAT)
    Trop Med Int Health; 2001 Nov; 6(11):891-8. PubMed ID: 11703843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.